TenSixteen Bio Funding: $40M Raised, Series A (2022)
TenSixteen Bio has raised $40M in total funding. Latest round: Series A. Backed by ARCH Venture Partners, Foresite Capital, GV.
TenSixteen Bio funding overview
TenSixteen Bio has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for TenSixteen Bio runs through 2022; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital. 6 distinct backers are named across the disclosed rounds.
TenSixteen Bio at a glance
Total raised
$40M
Latest round
Series A
Latest round date
January 2022
Notable investors
ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital
Frequently asked about TenSixteen Bio funding
How much has TenSixteen Bio raised?
TenSixteen Bio has raised $40M in total disclosed funding across the rounds on record.
Who has invested in TenSixteen Bio?
ARCH Venture Partners, Foresite Capital, GV, Mithril Capital Management, Polaris Partners, RA Capital are named among the investors backing TenSixteen Bio.
What was the latest TenSixteen Bio funding round?
The most recent disclosed round is a Series A, announced in January 2022.
Where is TenSixteen Bio based?
No headquarters location is disclosed for TenSixteen Bio.
When did TenSixteen Bio last raise?
The last disclosed TenSixteen Bio round closed in January 2022 at Series A.
Round data for TenSixteen Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
